Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection Emboline, Inc. has unveiled groundbreaking results from its PROTECT H2H trial, showcasing the Emboliner® system's potential in TAVR procedures. This innovative approach promises to redefine embolic protection standards in cardiac interventions.

Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection #USA #TAVR #Santa_Cruz #Emboliner #ACC_2026

Emboline's PROTECT H2H Trial Showcases Significant Advances in TAVR Embolic Protection Device Discover the groundbreaking results of Emboline's PROTECT H2H trial, presenting Emboliner® as a game-changer in TAVR procedures during ACC 2026.

Emboline's PROTECT H2H Trial Showcases Significant Advances in TAVR Embolic Protection Device #USA #TAVR #Santa_Cruz #Emboliner #ACC_2026

Emboline, Inc. Closes $20 Million Funding to Enhance Embolic Protection System Innovation Emboline, Inc. has secured $20 million from Trinity Capital to advance the commercialization of its Emboliner® system, which aims to reduce stroke risk during heart procedures.

Emboline, Inc. Closes $20 Million Funding to Enhance Embolic Protection System Innovation #USA #Santa_Cruz #Trinity_Capital #Emboline #Emboliner

Emboline, Inc. Secures $20 Million for Product Launch of the Emboliner® System in Stroke Prevention Emboline, Inc. announces successful acquisition of $20 million in funding from Trinity Capital to support the launch of the Emboliner® Embolic Protection System aimed at minimizing stroke risk during TAVR procedures.

Emboline, Inc. Secures $20 Million for Product Launch of the Emboliner® System in Stroke Prevention #USA #Santa_Cruz #Trinity_Capital #Emboline #Emboliner

Emboline, Inc. Marks Milestone in Embolic Protection with Completion of Trial Enrollment for Innovative Catheter Emboline, Inc. has successfully finished patient enrollment for its pivotal clinical trial focusing on the Emboliner® Embolic Protection Catheter, aimed at ensuring patient safety during TAVR procedures.

Emboline, Inc. Marks Milestone in Embolic Protection with Completion of Trial Enrollment for Innovative Catheter #USA #TAVR #Santa_Cruz #Emboline #Emboliner

Emboline, Inc. Finalizes Patient Enrollment for Pivotal IDE Trial of Emboliner Catheter Designed for TAVR Procedures Emboline, Inc. has completed patient enrollment in a key IDE trial for their Emboliner® device, aimed at protecting patients during TAVR procedures. This milestone represents a significant step toward enhanced patient safety.

Emboline, Inc. Finalizes Patient Enrollment for Pivotal IDE Trial of Emboliner Catheter Designed for TAVR Procedures #USA #TAVR #Santa_Cruz #Emboline #Emboliner